172 related articles for article (PubMed ID: 6176053)
21. Ultraviolet light induces tumors with both unique and host-associated antigenic specificities.
DeWitt CW
J Immunol; 1981 Jul; 127(1):329-34. PubMed ID: 6165770
[TBL] [Abstract][Full Text] [Related]
22. Tumor growth and evasion of immune destruction: UV-induced tumors as a model.
Mullen CA; Schreiber H
Surv Immunol Res; 1985; 4(4):264-70. PubMed ID: 2941841
[TBL] [Abstract][Full Text] [Related]
23. Differential antigen presentation in tumor immunity.
Schatten S; Drebin JA; Granstein RD; Greene MI
Fed Proc; 1984 Jun; 43(9):2460-4. PubMed ID: 6327399
[TBL] [Abstract][Full Text] [Related]
24. Tumour-associated transplantation antigens of chemically induced sarcomata cross reacting with allogeneic histocompatibility antigens.
Invernizzi G; Parmiani G
Nature; 1975 Apr; 254(5502):713-4. PubMed ID: 1091865
[No Abstract] [Full Text] [Related]
25. Suppressor cell clones specific for ultraviolet radiation-induced tumors. Function and surface proteins.
Trial J; McIntyre BW
J Immunol; 1990 Oct; 145(7):2044-9. PubMed ID: 1975821
[TBL] [Abstract][Full Text] [Related]
26. Antigenic characteristics of murine leukemia induced by chemical carcinogens.
Colnaghi MI; Della Porta G
Bibl Haematol; 1973; 39():595-602. PubMed ID: 4591438
[No Abstract] [Full Text] [Related]
27. Cell-mediated immune response to syngeneic UV-induced tumors. IV. The presence of I-A and I-E subregion-coded antigens on the accessory cell required for the in vitro differentiation of cytotoxic T lymphocytes.
Woodward JG; Daynes RA
J Immunol; 1979 Sep; 123(3):1227-31. PubMed ID: 112187
[No Abstract] [Full Text] [Related]
28. Immune response to somatic cell hybrids between ultraviolet radiation-induced regressor and spontaneous progressor C3H mouse tumor cells.
Chen PW; Kaba DS; Ananthaswamy HN
Cancer Res; 1990 Mar; 50(5):1544-9. PubMed ID: 2137370
[TBL] [Abstract][Full Text] [Related]
29. Suppressor T lymphocytes control the development of primary skin cancers in ultraviolet-irradiated mice.
Fisher MS; Kripke ML
Science; 1982 Jun; 216(4550):1133-4. PubMed ID: 6210958
[TBL] [Abstract][Full Text] [Related]
30. [In vivo quantitative analysis of immune reactions to solid murine tumors in syngeneic hosts].
Donner M; Oth D; Vaillier D; Burg C
Int J Cancer; 1972 Jan; 9(1):30-8. PubMed ID: 5015668
[No Abstract] [Full Text] [Related]
31. Demonstration in vitro of cytotoxic T cells with apparent specificity toward tumor-specific transplantation antigens on chemically induced tumors.
Chauvenet PH; McArthur CP; Smith RT
J Immunol; 1979 Dec; 123(6):2575-81. PubMed ID: 315425
[TBL] [Abstract][Full Text] [Related]
32. Cross-reactive transplantation antigens between UV-irradiated skin and UV-induced tumors.
Spellman CW; Daynes RA
Photodermatol; 1984 Aug; 1(4):164-9. PubMed ID: 6397735
[TBL] [Abstract][Full Text] [Related]
33. Generation of antigenic variants from a nonantigenic murine tumor cell line by transfection with a gene encoding a novel tumor-specific transplantation antigen.
Kaba DS; McIntyre BW; Kripke ML; Goodenow RS; Schreiber H; Ananthaswamy HN
Cancer Res; 1989 Jan; 49(1):38-43. PubMed ID: 2783244
[TBL] [Abstract][Full Text] [Related]
34. Cell-mediated immune response to syngeneic ultraviolet-induced tumors. II. The properties and antigenic specificities of cytotoxic T lymphocytes generated in vitro following removal from syngeneic tumor-immunized mice.
Daynes RA; Fernandez PA; Woodward JG
Cell Immunol; 1979 Jul; 45(2):398-414. PubMed ID: 89010
[No Abstract] [Full Text] [Related]
35. Latency, histology, and antigenicity of tumors induced by ultraviolet light in three inbred mouse strains.
Kripke ML
Cancer Res; 1977 May; 37(5):1395-400. PubMed ID: 851959
[No Abstract] [Full Text] [Related]
36. Immune response to progressor variants derived from transfection of an ultraviolet radiation-induced C3H mouse regressor tumor cell line with activated Harvey-ras oncogene.
Kaba DS; Pierceall WE; Price JE; Ananthaswamy HN
Cancer Res; 1990 Jun; 50(11):3159-66. PubMed ID: 2185882
[TBL] [Abstract][Full Text] [Related]
37. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
Weinhold KJ; Wheelock EF
Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
[TBL] [Abstract][Full Text] [Related]
38. Regulation of the immune response to antigens on the malignant cell surface.
Drebin JA; Perry LL; Carter R; Greene MI
Springer Semin Immunopathol; 1982; 5(2):175-92. PubMed ID: 6293112
[No Abstract] [Full Text] [Related]
39. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. VI. Similar specificity patterns of protective anti-tumor immunity in vivo and of cytolytic T cells in vitro.
Bosslet K; Schirrmacher V; Shantz G
Int J Cancer; 1979 Sep; 24(3):303-13. PubMed ID: 314938
[No Abstract] [Full Text] [Related]
40. Comparison of tumor-associated transplantation antigens of sublines of methylcholanthrene-induced murine tumors passaged separately in vivo for over a decade.
Hines DL
Cancer Res; 1986 Oct; 46(10):4921-6. PubMed ID: 3489516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
